Timeline Entry

Smallpox Vaccination, 1796

On 14 May 1796, in Berkeley, Gloucestershire, Edward Jenner inserted material from a cowpox lesion on the hand of dairy worker Sarah Nelmes into the arm of eight-year-old James Phipps. Six weeks later he deliberately exposed Phipps to smallpox by variolation; Jenner reported that the boy did not develop the expected disease. The experiment became the best-known episode in the origin of vaccination, but neither prevention nor the use of cowpox began with Jenner.

The importance of 1796 lies less in a lone moment of discovery than in what followed: Jenner's systematic published case for cowpox inoculation, efforts to keep vaccine material alive and transport it, and disputes over evidence, consent, compulsion and access that shaped smallpox control for nearly two centuries.

Before Jenner

Vaccination grew from older preventive knowledge

Long before 1796, people deliberately induced a usually milder case of smallpox in the hope of preventing a later, more dangerous infection. In English this came to be called inoculation, and historians now generally call it variolation to distinguish it from vaccination. It used material from a person with smallpox, so recipients could become seriously ill and transmit the disease to others.

Several traditions preceded 1721

Surviving accounts document different forms of variolation in China, parts of South Asia, the Ottoman Empire, North Africa and Europe. Their ultimate origin remains uncertain: written evidence is uneven, and later claims of great antiquity cannot always be verified. In colonial Massachusetts, the knowledge of the enslaved West African man Onesimus informed Cotton Mather's advocacy during the 1721 epidemic.

Montagu was a broker, not an inventor

Lady Mary Wortley Montagu observed Ottoman practitioners in Constantinople, arranged for her son to be variolated there and, in 1721, had her daughter variolated in England. Her elite position helped the practice enter British debate; it did not make the underlying knowledge European in origin.

Cowpox protection was local knowledge

Dairy workers and rural practitioners in south-west England already associated cowpox with resistance to smallpox. During a 1774 outbreak, the Dorset farmer Benjamin Jesty deliberately gave cowpox to his wife and two sons. Jenner therefore was not the first person known to attempt cowpox inoculation; his distinctive contribution was to investigate it, publish a case-based argument and promote a repeatable practice.

Arthur Boylston's review of the surviving evidence cautions against assigning variolation a simple national origin, while Alfredo Morabia's analysis places Jenner's work within this longer sequence of preventive trials. Their accounts also show why “Jenner invented prevention” is historically misleading.

Experiment And Publication

What happened in 1796—and what the evidence could show

Jenner was a surgeon and general practitioner in a dairying district. On 14 May he used material from a lesion on Sarah Nelmes's hand to inoculate James Phipps, the son of a labourer employed by Jenner. Jenner's later account says that Phipps experienced local discomfort, fever and a brief illness. On 1 July Jenner variolated him with smallpox material; the expected signs of a successful smallpox inoculation did not appear.

One case was not a modern clinical trial and did not establish duration of protection, frequency of failure or comparative risk. Jenner waited until cowpox reappeared locally, conducted further transfers in 1798 and showed that material taken from one vaccinated child could be passed through a succession of people without apparently losing its effect. These practical demonstrations made sustained vaccination possible.

In 1798 Jenner privately published An Inquiry into the Causes and Effects of the Variolæ Vaccinæ. Its twenty-three numbered case histories combined reports of naturally acquired cowpox with deliberate experiments. It is an indispensable primary source, but it was also Jenner's argument for his own theory and method, not a neutral record. Some of his explanations— especially his proposed derivation of cowpox from the equine disease called “grease”—were disputed even then. The biological identity of material used under the names cowpox and “vaccine lymph” also changed or varied; the vaccinia virus used in later vaccines is distinct from both variola and currently recognised cowpox viruses, and its origin remains debated.

  1. 1774: Benjamin Jesty uses cowpox material on his wife and two sons in Dorset during a smallpox outbreak.
  2. 14 May 1796: Jenner inoculates James Phipps with material from Sarah Nelmes's cowpox lesion.
  3. 1 July 1796: Jenner variolates Phipps to test whether the earlier procedure had protected him.
  4. 1798: further cases include serial person-to-person transfers; Jenner publishes his Inquiry in London.

Patients And Ethics

The celebrated experiment depended on a child with little power

Phipps was eight years old and the son of a poor labourer. Jenner's Inquiry records the procedures and symptoms but does not document permission from Phipps's parents or assent from the child. The experiment therefore cannot answer the questions about consent that a modern reader should ask. Jenner also deliberately exposed Phipps to variola material—a dangerous pathogen for which there was no curative treatment.

Historical context matters without settling the ethical judgment. Variolation was an accepted preventive option in eighteenth-century England and usually carried less danger than naturally acquired smallpox; if cowpox had failed to protect Phipps, Jenner expected the variolation to give him the immunity sought in ordinary practice. Even so, contemporary standards for research with children, valid consent and human challenge studies would not permit this design. Later heroic retellings that mention Jenner while reducing Nelmes to “a milkmaid” and Phipps to “a test boy” hide the labour and unequal social relations on which the experiment depended.

Circulation And Empire

Vaccination was a fragile material system

Publication alone could not spread vaccination. Early practitioners needed active lymph from a recent lesion. They tried dried threads, lancets, ivory points and sealed glass plates, but heat, delay or mishandling could make material ineffective. They also needed descriptions and coloured images to distinguish an expected vaccine lesion from other sores and to judge whether a procedure had “taken.”

The most reliable early method was arm-to-arm transfer: lymph was collected from one vaccinated person's lesion and inserted into another. This made children and other recipients part of the supply chain. It could spread skin infection and, in some circumstances, blood-borne disease; it also enabled institutions to draw material disproportionately from foundlings, poor families and other people with limited power. From the mid-nineteenth century, production in calves increasingly offered an alternative, although quality and contamination still required control.

Andrea Rusnock has shown that by 1810 vaccination had been established, at least temporarily, in parts of Europe, Asia and the Americas through the work of physicians, clergy, philanthropists, officials and recipients. This was also a history of empire. The Spanish Crown's 1803 expedition under Francisco Xavier Balmis carried vaccine across the Atlantic by sequentially vaccinating twenty-two foundling boys under ten; more children were recruited as the expedition continued through Spanish territories. The voyage preserved viable vaccine and founded local institutions, but its humanitarian purpose cannot be separated from colonial administration or from the use of dependent children as living carriers.

In Britain, the National Vaccine Establishment was created in 1808 to offer vaccination and distribute lymph. Such institutions—not Jenner alone—made vaccination reproducible by training practitioners, maintaining supplies, inspecting lesions and recording procedures.

Law And Resistance

Protection became an argument about bodies and state power

England and Wales provide one influential, but not universal, legal sequence. The Vaccination Act 1840 made vaccination available through Poor Law authorities and prohibited variolation. The 1853 Act required infant vaccination, and later legislation strengthened registration and penalties. In 1898 Parliament added a conscience clause through which objecting parents could seek exemption. Other states and empires adopted different mixtures of persuasion, subsidy, certification and compulsion.

Opposition cannot be reduced to ignorance or a single timeless “anti-vaccine” position. Historian Nadja Durbach shows that many Victorian English campaigners objected to repeated fines, class-biased enforcement, intrusion into family authority and a procedure they believed could contaminate their children's bodies. Some claims about vaccination were medically wrong, but concerns about unsafe technique and arm-to-arm contamination had a material basis. Women often bore the work of compliance and appeared before magistrates, while working-class families faced the sharpest penalties. Vaccine politics therefore joined evidence about protection to questions of trust, safety, citizenship and bodily authority.

Eradication And Legacy

Vaccination was necessary, but no single experiment eradicated smallpox

Improved vaccine production, stable freeze-dried preparations, national programmes and international cooperation eventually made global eradication feasible. The World Health Assembly called for eradication in 1958, and the World Health Organization began an intensified programme in 1967. Its work combined vaccination with vaccine quality control, case reporting, active searches, laboratory confirmation and rapid containment of contacts and outbreaks. Local health workers and national programmes in endemic countries supplied much of the labour and funding.

The last known naturally occurring case was recorded in Somalia in 1977; after international verification, the World Health Assembly endorsed global eradication in 1980. That achievement documents vaccination's extraordinary value, but it should not be projected backwards as proof that every claim in Jenner's Inquiry was correct. Nor was it his accomplishment alone. Eradication depended on nearly two centuries of changing viruses and production methods, public participation, contested laws, field surveillance and work by many institutions across regions where smallpox persisted long after it had receded from wealthy states.

  1. 1803: the Balmis expedition begins carrying vaccine through Spanish imperial territories by arm-to-arm transfer among children.
  2. 1808: Britain establishes the National Vaccine Establishment.
  3. 1840–1898: British statutes move from free provision and a ban on variolation to compulsion, stronger enforcement and then conscientious exemption.
  4. 1967: WHO begins its Intensified Smallpox Eradication Programme.
  5. 1977: the last known naturally occurring case is recorded in Somalia.
  6. 1980: the World Health Assembly endorses the certification of global eradication.

References

Sources for the history of smallpox vaccination

  1. Edward Jenner, An Inquiry into the Causes and Effects of the Variolæ Vaccinæ (London: printed for the author, 1798)

    Digitised primary source and catalogue record from Wellcome Collection. Jenner assembled the observations and experiments to advocate his method; it should be read as a participant's publication, not as an independent assessment or a record of consent.

  2. Arthur W. Boylston, “The Origins of Inoculation”, Journal of the Royal Society of Medicine 105, no. 7 (2012): 309–313

    A critical review of evidence for variolation in Europe, Africa, Asia, the Ottoman world and colonial New England, including the limits of origin claims.

  3. Alfredo Morabia, “Edward Jenner's 1798 Report of Challenge Experiments Demonstrating the Protective Effects of Cowpox against Smallpox”, JLL Bulletin (2010; republished in Journal of the Royal Society of Medicine 111 [2018]: 255–257)

    Reconstructs the case sequence, distinguishes Jesty's earlier procedure from Jenner's systematic account and explains what the 1798 evidence did and did not establish.

  4. Andrea Rusnock, “Catching Cowpox: The Early Spread of Smallpox Vaccination, 1798–1810”, Bulletin of the History of Medicine 83, no. 1 (2009): 17–36

    Peer-reviewed study of vaccine lymph, transport, arm-to-arm transfer, institutions and the people whose bodies maintained early supply chains.

  5. Nadja Durbach, Bodily Matters: The Anti-Vaccination Movement in England, 1853–1907 (Durham, NC: Duke University Press, 2005)

    A social and political history of compulsion, working-class resistance, gender, bodily integrity and the development of conscientious objection.

  6. Ben Bambery et al., “Ethical Criteria for Human Challenge Studies in Infectious Diseases”, Public Health Ethics 9, no. 1 (2016): 92–103

    A modern bioethical framework used here to distinguish the eighteenth- century setting of Phipps's exposure from present requirements for adult consent, risk review and protection of participants.

  7. Frank Fenner, Donald A. Henderson, Isao Arita, Zdeněk Ježek and Ivan D. Ladnyi, Smallpox and Its Eradication (Geneva: World Health Organization, 1988)

    The comprehensive institutional history by participants in eradication; especially useful for vaccine production, programme strategy, country campaigns and certification.

  8. World Health Organization, “History of Smallpox Vaccination” and “Smallpox Eradication Programme, 1966–1980”

    Concise institutional accounts of the intensified programme, surveillance- containment, the 1977 last natural case and the 1980 declaration.